Patents by Inventor Bradley Gates

Bradley Gates has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Novel glucocorticoid receptor ligands for the treatment of metabolic disorders
    Publication number: 20070027117
    Abstract: This invention relates to novel compounds that are liver selective glucocorticoid receptor antagonists, to methods of preparing such compounds, and to methods for using such compounds in the regulation of metabolism, especially lowering serum glucose levels, insulin levels, or lipid levels, and/or decreasing body weight.
    Type: Application
    Filed: July 21, 2006
    Publication date: February 1, 2007
    Inventors: Richard Bishop, Russell Cink, Bradley Gates, Lars Hagberg, Peer Jacobsen, Philip Kym, Chunqiu Lai, Marvin Leanna, James Link, Steven Richards, Noah Tu, Tom von Geldern
  • Synthesis of acyclic nucleoside derivatives
    Publication number: 20050250795
    Abstract: Methods and novel intermediates for the preparation of acyclic nucleoside derivatives of the formula: where one of R1 and R2 is an amino acid acyl group and the other of R1 and R2 is a —C(O)C3-C21 saturated or monounsaturated, optionally substituted alkyl and R3 is OH or H; or a pharmaceutically acceptable salt thereof.
    Type: Application
    Filed: May 18, 2005
    Publication date: November 10, 2005
    Applicant: Medivir AB
    Inventors: M. Leanna, Steven Hannick, Michael Rasmussen, Jien-Heh Tien, Lakshmi Bhagavatula, Pulla Singam, Bradley Gates, Lawrence Kolaczkowski, Ramesh Patel, Greg Wayne, Greg Lannoye, Weijiang Zhang, Zhenping Tian, Kirill Lukin, Bikshandarkoil Narayanan, David Riley, Howard Morton, Sou-Jen Chang, Cynthia Curty, Daniel Plata, John Bellettini, Bhadra Shelat, Tiffany Spitz, Cheng-Xi Yang
  • Anti-infective agents
    Publication number: 20050107364
    Abstract: Compounds having the formula are hepatitis C (HCV) polymerase inhibitors. Also disclosed are a composition and method for inhibiting hepatitis C (HCV) polymerase, processes for making the compounds, and synthetic intermediates employed in the processes.
    Type: Application
    Filed: August 24, 2004
    Publication date: May 19, 2005
    Inventors: Douglas Hutchinson, John Bellettini, David Betebenner, Richard Bishop, Thomas Borchardt, Todd Bosse, Russell Cink, Charles Flentge, Bradley Gates, Brian Green, Mira Hinman, Peggy Huang, Larry Klein, Allan Krueger, Daniel Larson, M. Leanna, Dachun Liu, Darold Madigan, Keith McDaniel, John Randolph, Todd Rockway, Teresa Rosenberg, Kent Stewart, Vincent Stoll, Rolf Wagner, Ming Yeung